Elixxer Ltd. (ELIXF)
OTCMKTS
· Delayed Price · Currency is USD
0.0013
0.00 (0.00%)
At close: Jun 18, 2025
Elixxer Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.74K USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| American Oncology Network | 1.76B |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Elixxer News
- 15 days ago - Elixxer Announces Bridge Loan - Newsfile Corp
- 2 months ago - Elixxer Ltd.: Revocation of Cease Trade Order - Newsfile Corp
- 3 months ago - Elixxer Announces Results of Annual and Special Meeting of Shareholders - Newsfile Corp
- 4 months ago - Elixxer Announces Appointment of Edward Milewski as a Director - Newsfile Corp
- 5 months ago - Elixxer Announces Appointment of Mark Romano as a Director - Newsfile Corp
- 7 months ago - Elixxer Announces Appointment of Fiona Fitzmaurice as Chief Financial Officer - Newsfile Corp
- 7 months ago - Elixxer Announces Appointment of Karim Mecklai as Chief Executive Officer - Newsfile Corp
- 2 years ago - Elixxer Ltd. Announces Appointment of New Auditor - Newsfile Corp